Health care · Updated 18 September 2026 · 9 min read
Pharmaceutical Companies' Employee Compensation
The broad health-care category includes pharmaceutical, medical-device, diagnostics and other health businesses. The results below show the company-level compensation distribution across that wider group.
Quick answer
Among 477 A-share health-care companies, median reported average compensation was CN¥179,261 in 2025, compared with a mean of CN¥201,755.
Companies
477
Broad health-care group
2025 median
CN¥179,261
Company observations
2025 mean
CN¥201,755
Sensitive to outliers
Different businesses within the category
A research-heavy drug developer and a business with a large manufacturing workforce have different staff mixes. The company table is a starting point for disclosure research, not a ranking adjusted for those subindustry differences.
Top 30 health-care compensation observations in 2025
Methodology and limitations
- Average compensation is derived from company-reported employee and compensation figures. It is not the salary received by every employee and does not describe individual pay.
- We use the median to reduce the effect of unusually large observations and show the mean as a separate comparison.
- Missing values are excluded. Year-to-year comparisons include only companies with data in both periods.
- This article is factual data analysis. It is not investment advice, a stock recommendation, or an asset-management service.
- The sample includes companies in the database broad category 医药卫生 (Health Care).